X

Trial Profile

A Prospective, Multicenter, Open Label Extension Study to Evaluate the Long Term Safety of OTX-TP

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 01 Mar 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Travoprost (Primary)
Indications Ocular hypertension; Open-angle glaucoma
Focus Adverse reactions; Registrational; Therapeutic Use
Sponsors Ocular Therapeutix

Most Recent Events

10 Aug 2021 Status changed from active, no longer recruiting to completed.
05 Aug 2021 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Aug 2019).
15 Aug 2019 Status changed from planning to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com